"DMI Research provides opportunities for the community to participate in clinical studies for many different medical conditions. Single visit and long term studies are available with study physicians and staff. Conveniently located, volunteers can participate easily. We offer extended hours if needed to help people access treatments that may benefit them. We are focused on quality research to advance medicine in our community. We have overnight capabilities to ensure the safety of participants in early phase studies. DMI Research offers compassionate care with professional staff in a relaxed atmosphere."

During the past decade, DMI Research, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 19 clinical trials were completed, i.e. on average, 211.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DMI Research, Inc." #1 sponsor was "Pfizer" with 7 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DMI Research, Inc." #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "DMI Research, Inc." are "Intermittent Claudication" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Cardiovascular Disease" (2 trials), "Nocturia" (2 trials) and "Peripheral Artery Disease" (2 trials). Many other conditions were trialed in "DMI Research, Inc." in a lesser frequency.

Most popular intervention types in "DMI Research, Inc." are "Drug" (27 trials), "Biological" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Desmopressin" (2 trials), "Oseltamivir" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "DMI Research, Inc." are 25 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "DMI Research, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in DMI Research, Inc., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in DMI Research, Inc., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".